Source: New feed
[at TheStreet] - An estimate that the augmented reality game could produce $3 billion in…
New Suitor Reportedly Replaced J&J in This $20 Billion Biotech Deal
Switzerland's Actelion is in talks with French drugmaker Sanofi about a deal, sources said on Wednesday, after U.S. healthcare group Johnson & Johnson abandoned efforts to buy the company. Actelion's aliof shares traded 10% lower amid concern among ...
Sanofi in talks to buy biotech Actelion as J&J bows outFinancial Times
Actelion Stock Hits Record High on Speculation of Sanofi Takeover ApproachTheStreet.com
Sanofi Is in Talks for Deal With Actelion PharmaceuticalsWall Street Journal
all 121 news articles »